{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:55:39Z","timestamp":1790834139880,"version":"4.1.0"},"reference-count":223,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.blre.2020.100760","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T17:03:41Z","timestamp":1600794221000},"page":"100760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Challenging the concept of de novo acute myeloid leukemia: Environmental and occupational leukemogens hiding in our midst"],"prefix":"10.1016","volume":"47","author":[{"given":"Rory M.","family":"Shallis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian J.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole C.","family":"Deziel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Gore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2020.100760_bb0005","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature13038","article-title":"Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia","volume":"506","author":"Shlush","year":"2014","journal-title":"Nature."},{"key":"10.1016\/j.blre.2020.100760_bb0010","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1073\/pnas.1324297111","article-title":"Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission","volume":"111","author":"Corces-Zimmerman","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2020.100760_bb0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/ejh.13092","article-title":"The genetic and molecular pathogenesis of myelodysplastic syndromes","volume":"101","author":"Shallis","year":"2018","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2020.100760_bb0020","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2020.100760_bb0025","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2020.100760_bb0030","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature."},{"key":"10.1016\/j.blre.2020.100760_bb0035","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood-2016-09-670224","article-title":"Myeloid malignancies and the microenvironment","volume":"129","author":"Korn","year":"2017","journal-title":"Blood."},{"key":"10.1016\/j.blre.2020.100760_bb0040","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1038\/s41375-018-0049-5","article-title":"Germline alterations in a consecutive series of acute myeloid leukemia","volume":"32","author":"Wartiovaara-Kautto","year":"2018","journal-title":"Leukemia."},{"key":"10.1016\/j.blre.2020.100760_bb0045","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s12015-012-9384-5","article-title":"The evolving role of the aryl hydrocarbon receptor (AHR) in the normophysiology of hematopoiesis","volume":"8","author":"Lindsey","year":"2012","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.blre.2020.100760_bb0050","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood-2016-07-730440","article-title":"Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cells","volume":"129","author":"Angelos","year":"2017","journal-title":"Blood."},{"key":"10.1016\/j.blre.2020.100760_bb0055","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1158\/0008-5472.CAN-19-0274","article-title":"Diminished AHR Signaling drives human acute myeloid Leukemia stem cell maintenance","volume":"79","author":"Ly","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2020.100760_bb0060","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/nyas.12358","article-title":"Topoisomerase II and leukemia","volume":"1310","author":"Pendleton","year":"2014","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.blre.2020.100760_bb0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","article-title":"Epidemiology of acute myeloid leukemia: recent progress and enduring challenges","volume":"36","author":"Shallis","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2020.100760_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.blre.2018.09.001","article-title":"Epidemiology of myelodysplastic syndromes: why characterizing the beast is a prerequisite to taming it","volume":"34","author":"Zeidan","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2020.100760_bb0075","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1038\/leu.2017.238","article-title":"Therapy-related myelodysplastic syndromes-specific risk stratification: are we putting the cart before the horse?","volume":"31","author":"Zeidan","year":"2017","journal-title":"Leukemia."},{"key":"10.1016\/j.blre.2020.100760_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184747","article-title":"Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: a population-based study","volume":"12","author":"Zeidan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.blre.2020.100760_bb0085","doi-asserted-by":"crossref","first-page":"80103","DOI":"10.18632\/oncotarget.21178","article-title":"Risk stratification in therapy-related myelodysplastic syndromes","volume":"8","author":"Zeidan","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.blre.2020.100760_bb0090","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/leu.2017.33","article-title":"Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS clinical research consortium","volume":"31","author":"Zeidan","year":"2017","journal-title":"Leukemia."},{"key":"10.1016\/j.blre.2020.100760_bb0095","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1182\/blood-2012-08-448068","article-title":"Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008","volume":"121","author":"Morton","year":"2013","journal-title":"Blood."},{"key":"10.1016\/j.blre.2020.100760_bb0100","first-page":"937","article-title":"The incidence of secondary leukemias","volume":"84","author":"Leone","year":"1999","journal-title":"Haematologica."},{"key":"10.1016\/j.blre.2020.100760_bb0105","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1200\/JCO.2014.60.0890","article-title":"Epidemiology and clinical significance of secondary and therapy-related acute myeloid Leukemia: a National Population-Based Cohort Study","volume":"33","author":"Granfeldt Ostgard","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2020.100760_bb0110","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrc.2017.60","article-title":"Therapy-related myeloid neoplasms: when genetics and environment collide","volume":"17","author":"McNerney","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.blre.2020.100760_bb0115","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.stem.2017.07.010","article-title":"Therapy-related clonal Hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes","volume":"21","author":"Coombs","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.blre.2020.100760_bb0120","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jamaoncol.2015.6053","article-title":"Somatic mosaic mutations in PPM1D and TP53 in the blood of women with ovarian carcinoma","volume":"2","author":"Swisher","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.blre.2020.100760_bb0125","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/cncr.29615","article-title":"Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia","volume":"122","author":"Churpek","year":"2016","journal-title":"Cancer."},{"key":"10.1016\/j.blre.2020.100760_bb0130","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/jmedgenet-2011-100674","article-title":"Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms","volume":"49","author":"Schulz","year":"2012","journal-title":"J Med Genet"},{"key":"10.1016\/j.blre.2020.100760_bb0135","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/cncr.29096","article-title":"Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors","volume":"121","author":"Bhatia","year":"2015","journal-title":"Cancer."},{"key":"10.1016\/j.blre.2020.100760_bb0140","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1182\/blood.V120.21.3557.3557","article-title":"Comparing outcomes of patients with secondary AML: treatment-related MDS\/AML, AML secondary to Myeloproliferative neoplasms (t-MPN), and AML with prior malignancies","volume":"120","author":"Yi","year":"2012","journal-title":"Blood."},{"key":"10.1016\/j.blre.2020.100760_bb0145","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1182\/bloodadvances.2017008227","article-title":"Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosis","volume":"1","author":"Boddu","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2020.100760_bb0150","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.leukres.2014.12.006","article-title":"Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases","volume":"39","author":"Ok","year":"2015","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2020.100760_bb0155","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.leu.2403187","article-title":"Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML","volume":"18","author":"Schoch","year":"2004","journal-title":"Leukemia."},{"key":"10.1016\/j.blre.2020.100760_bb0160","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1002\/cncr.30203","article-title":"TP53 mutations in newly diagnosed acute myeloid leukemia: Clinicomolecular characteristics, response to therapy, and outcomes","volume":"122","author":"Kadia","year":"2016","journal-title":"Cancer."},{"key":"10.1016\/j.blre.2020.100760_bb0165","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature13968","article-title":"Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia","volume":"518","author":"Wong","year":"2015","journal-title":"Nature."},{"issue":"4","key":"10.1016\/j.blre.2020.100760_bb0170","first-page":"1","article-title":"Therapy-related AML and MDS: who really has it?","volume":"12","author":"Gale","year":"2015","journal-title":"Hematologist"},{"key":"10.1016\/j.blre.2020.100760_bb0175","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3109\/10428194.2012.717275","article-title":"Patients with therapy-related myelodysplastic syndromes and acute myeloid leukemia share genetic features but can be separated by blast counts and cytogenetic risk profiles into prognostically relevant subgroups","volume":"54","author":"Bacher","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2020.100760_bb0180","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7326\/0003-4819-59-3-369","article-title":"Leukemia and Hodgkin's disease","volume":"59","author":"Lacher","year":"1963","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2020.100760_bb0185","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1001\/archinte.1970.00310030106013","article-title":"Acute granulocytic leukemia complicating Hodgkin's disease","volume":"125","author":"Steinberg","year":"1970","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.blre.2020.100760_bb0190","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1056\/NEJM199206253262605","article-title":"Risk of leukemia after chemotherapy and radiation treatment for breast cancer","volume":"326","author":"Curtis","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2020.100760_bb0195","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1200\/JCO.2012.44.5791","article-title":"Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials","volume":"31","author":"Koontz","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2020.100760_bb0200","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood-2013-07-512657","article-title":"Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin study group","volume":"123","author":"Eichenauer","year":"2014","journal-title":"Blood."},{"key":"10.1016\/j.blre.2020.100760_bb0205","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jnci\/djj017","article-title":"Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patients","volume":"98","author":"Schonfeld","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.blre.2020.100760_bb0210","first-page":"1975","article-title":"Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series","volume":"7","author":"Pedersen-Bjergaard","year":"1993","journal-title":"Leukemia."},{"key":"10.1016\/j.blre.2020.100760_bb0215","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1200\/JCO.2001.19.5.1405","article-title":"Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis","volume":"19","author":"Christiansen","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2020.100760_bb0220","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/cncr.31144","article-title":"Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: a population-based study among older breast cancer patients","volume":"124","author":"Rosenstock","year":"2018","journal-title":"Cancer."},{"key":"10.1016\/j.blre.2020.100760_bb0225","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1200\/JCO.1992.10.9.1444","article-title":"Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer","volume":"10","author":"Pedersen-Bjergaard","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2020.100760_bb0230","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1200\/JCO.2003.03.114","volume":"21","author":"Smith","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2020.100760_bb0235","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.canep.2010.04.003","article-title":"Acute myeloid leukemia incidence following radiation therapy for localized or locally advanced prostate adenocarcinoma","volume":"34","author":"Ojha","year":"2010","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.blre.2020.100760_bb0240","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.breast.2005.11.007","article-title":"Increased risk of acute myeloid leukaemia after treatment for breast cancer","volume":"15","author":"Renella","year":"2006","journal-title":"Breast."},{"key":"10.1016\/j.blre.2020.100760_bb0245","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/pros.23281","article-title":"Myelodysplastic syndromes and acute myeloid Leukemia after radiotherapy for prostate cancer: a population-based study","volume":"77","author":"Wang","year":"2017","journal-title":"Prostate."},{"key":"10.1016\/j.blre.2020.100760_bb0250","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.annepidem.2008.01.003","article-title":"Risk of leukemia among survivors of testicular cancer: a population-based study of 42,722 patients","volume":"18","author":"Howard","year":"2008","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.blre.2020.100760_bb0255","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood-2002-11-3343","article-title":"Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series","volume":"102","author":"Smith","year":"2003","journal-title":"Blood."},{"key":"10.1016\/j.blre.2020.100760_bb0260","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1200\/JCO.2011.38.7340","article-title":"Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms","volume":"30","author":"Nardi","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2020.100760_bb0265","first-page":"1","article-title":"Tobacco smoke and involuntary smoking","volume":"83","author":"Humans IWGotEoCRt","year":"2004","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"10.1016\/j.blre.2020.100760_bb0270","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.23744","article-title":"The relation between cigarette smoking and risk of acute myeloid leukemia: an updated meta-analysis of epidemiological studies","volume":"89","author":"Fircanis","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2020.100760_bb0275","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ijc.30420","article-title":"Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study","volume":"140","author":"Poynter","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.blre.2020.100760_bb0280","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.critrevonc.2016.01.003","article-title":"Do the smoking intensity and duration, the years since quitting, the methodological quality and the year of publication of the studies affect the results of the meta-analysis on cigarette smoking and acute myeloid Leukemia (AML) in adults?","volume":"99","author":"Colamesta","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.blre.2020.100760_bb0285","article-title":"Cigarette smoking and the risk of adult myeloid disease: a meta-analysis","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.blre.2020.100760_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.leukres.2009.08.006","article-title":"Smoking and alcohol intake as risk factors for myelodysplastic syndromes (MDS)","volume":"34","author":"Du","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2020.100760_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067537","article-title":"A meta-analysis of the relationship between cigarette smoking and incidence of Myelodysplastic syndromes","volume":"8","author":"Tong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.blre.2020.100760_bb0300","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1093\/jnci\/85.24.1994","article-title":"Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow","volume":"85","author":"Sandler","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.blre.2020.100760_bb0305","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/jama.1989.03430050050025","article-title":"Environmental exposures in cytogenetically defined subsets of acute nonlymphocytic leukemia","volume":"262","author":"Crane","year":"1989","journal-title":"JAMA."},{"key":"10.1016\/j.blre.2020.100760_bb0310","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/sj.bjc.6600010","article-title":"Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups","volume":"86","author":"Moorman","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.blre.2020.100760_bb0315","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.leukres.2008.10.009","article-title":"Smoking as a risk factor for myelodysplastic syndromes and acute myeloid leukemia and its relation to cytogenetic findings: a case-control study","volume":"33","author":"Bjork","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2020.100760_bb0320","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0145-2126(01)00048-0","article-title":"Smoking and acute myeloid leukemia: associations with morphology and karyotypic patterns and evaluation of dose-response relations","volume":"25","author":"Bjork","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2020.100760_bb0325","first-page":"639","article-title":"Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia","volume":"5","author":"Crane","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.blre.2020.100760_bb0330","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ajim.4700170607","article-title":"But they are not thresholds: a critical analysis of the documentation of threshold limit values","volume":"17","author":"Roach","year":"1990","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.blre.2020.100760_bb0335","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ajim.22087","article-title":"Occupational benzene exposure and the risk of chronic myeloid leukemia: a meta-analysis of cohort studies incorporating study quality dimensions","volume":"55","author":"Vlaanderen","year":"2012","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.blre.2020.100760_bb0340","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1056\/NEJM196410222711703","article-title":"Benzene and Leukemia","volume":"271","author":"Vigliani","year":"1964","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2020.100760_bb0345","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood.V44.6.837.837","article-title":"Leukemia in shoe-workers exposed chronically to benzene","volume":"44","author":"Aksoy","year":"1974","journal-title":"Blood."},{"key":"10.1016\/j.blre.2020.100760_bb0350","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1182\/blood.V52.2.285.285","article-title":"Followup study on the mortality and the development of leukemia in 44 pancytopenic patients with chronic exposure to benzene","volume":"52","author":"Aksoy","year":"1978","journal-title":"Blood."},{"key":"10.1016\/j.blre.2020.100760_bb0355","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0013-9351(76)90115-8","article-title":"Benzene and leukemia","volume":"11","author":"Vigliani","year":"1976","journal-title":"Environ Res"},{"key":"10.1016\/j.blre.2020.100760_bb0360","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ajim.4700020305","article-title":"Leukemia in benzene workers","volume":"2","author":"Rinsky","year":"1981","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.blre.2020.100760_bb0365","first-page":"41","article-title":"Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1 to 42","volume":"7","author":"IARC","year":"1987","journal-title":"IARC Monogr Eval Carcinog Risks Hum Suppl"},{"key":"10.1016\/j.blre.2020.100760_bb0370","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/jnci\/89.14.1065","article-title":"Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese academy of preventive medicine\u2014National Cancer Institute benzene study group","volume":"89","author":"Hayes","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.blre.2020.100760_bb0375","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/jnci\/djy143","article-title":"Benzene exposure response and risk of myeloid neoplasms in Chinese workers: a Multicenter case-cohort study","volume":"111","author":"Linet","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.blre.2020.100760_bb0380","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1002\/ijc.29591","article-title":"A retrospective cohort study of cause-specific mortality and incidence of hematopoietic malignancies in Chinese benzene-exposed workers","volume":"137","author":"Linet","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.blre.2020.100760_bb0385","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/(SICI)1097-0274(199603)29:3<236::AID-AJIM3>3.0.CO;2-O","article-title":"Hematotoxicity among Chinese workers heavily exposed to benzene","volume":"29","author":"Rothman","year":"1996","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.blre.2020.100760_bb0390","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1196\/annals.1371.024","article-title":"The health watch case-control study of leukemia and benzene: the story so far","volume":"1076","author":"Glass","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.blre.2020.100760_bb0395","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/jnci\/djs411","article-title":"Myelodysplastic syndrome and benzene exposure among petroleum workers: an international pooled analysis","volume":"104","author":"Schnatter","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.blre.2020.100760_bb0400","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/bjc.2013.780","article-title":"Acute myeloid and chronic lymphoid leukaemias and exposure to low-level benzene among petroleum workers","volume":"110","author":"Rushton","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.blre.2020.100760_bb0405","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ije\/dyv121","article-title":"Cohort profile: health watch-a 30-year prospective cohort study of Australian petroleum industry workers","volume":"45","author":"Glass","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.blre.2020.100760_bb0410","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/15459624.2017.1339162","article-title":"Exposure to benzene in a pooled analysis of petroleum industry case-control studies","volume":"14","author":"Glass","year":"2017","journal-title":"J Occup Environ Hyg"},{"key":"10.1016\/j.blre.2020.100760_bb0415","first-page":"13","article-title":"Increased risk of acute myelogenous leukemia and multiple myeloma in a historical cohort of upstream petroleum workers exposed to crude oil","volume":"19","author":"Kirkeleit","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.blre.2020.100760_bb0420","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/bjc.2015.390","article-title":"Benzene exposure and risk of lymphohaematopoietic cancers in 25,000 offshore oil industry workers","volume":"113","author":"Stenehjem","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.blre.2020.100760_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16142545","article-title":"Risk assessment on benzene exposure among gasoline station workers","volume":"16","author":"Chaiklieng","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.blre.2020.100760_bb0430","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/00039896.1993.9940369","article-title":"Acute myeloid leukemia among petrol station attendants","volume":"48","author":"Jakobsson","year":"1993","journal-title":"Arch Environ Health"},{"key":"10.1016\/j.blre.2020.100760_bb0435","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.leukres.2005.03.002","article-title":"Occupation, hobbies, and acute leukemia in adults","volume":"29","author":"Terry","year":"2005","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2020.100760_bb0440","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1002\/cncr.27442","article-title":"De novo acute myeloid leukemia risk factors: a Texas case-control study","volume":"118","author":"Strom","year":"2012","journal-title":"Cancer."},{"key":"10.1016\/j.blre.2020.100760_bb0445","author":"Toxic and Hazardous Substances"},{"key":"10.1016\/j.blre.2020.100760_bb0455","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/(SICI)1097-0274(199603)29:3<247::AID-AJIM4>3.0.CO;2-N","article-title":"Risk of low red or white blood cell count related to estimated benzene exposure in a rubberworker cohort (1940-1975)","volume":"29","author":"Ward","year":"1996","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.blre.2020.100760_bb0460","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1102443","article-title":"Hematotoxicity in workers exposed to low levels of benzene","volume":"306","author":"Lan","year":"2004","journal-title":"Science."},{"key":"10.1016\/j.blre.2020.100760_bb0465","first-page":"1","volume":"69","year":"1997","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"10.1016\/j.blre.2020.100760_bb0470","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2105\/AJPH.2018.304426","article-title":"Agent orange during the Vietnam war: the lingering issue of its civilian and military health impact","volume":"108","author":"Stellman","year":"2018","journal-title":"Am J Public Health"},{"key":"10.1016\/j.blre.2020.100760_bb0475","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1002\/cncr.28962","article-title":"Challenges in investigating the association between agent Orange and cancer: site-specific cancer risk and accuracy of exposure assessment","volume":"120","author":"Sinks","year":"2014","journal-title":"Cancer."},{"key":"10.1016\/j.blre.2020.100760_bb0480","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1470-2045(02)00700-3","article-title":"Agent Orange no longer linked to childhood AML","volume":"3","author":"Ahmad","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.blre.2020.100760_bb0485","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00383591","article-title":"Thirty-four-year mortality follow-up of BASF employees exposed to 2,3,7,8-TCDD after the 1953 accident","volume":"62","author":"Zober","year":"1990","journal-title":"Int Arch Occup Environ Health"},{"key":"10.1016\/j.blre.2020.100760_bb0490","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/oem.2010.060426","article-title":"Plasma dioxin levels and cause-specific mortality in an occupational cohort of workers exposed to chlorophenoxy herbicides, chlorophenols and contaminants","volume":"69","author":"Boers","year":"2012","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.blre.2020.100760_bb0495","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/oxfordjournals.aje.a009069","article-title":"Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study","volume":"145","author":"Kogevinas","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.blre.2020.100760_bb0500","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/aje\/kwm371","article-title":"Mortality in a population exposed to dioxin after the Seveso, Italy, accident in 1976: 25 years of follow-up","volume":"167","author":"Consonni","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.blre.2020.100760_bb0505","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1476-069X-8-39","article-title":"Cancer incidence in the population exposed to dioxin after the \"Seveso accident\": twenty years of follow-up","volume":"8","author":"Pesatori","year":"2009","journal-title":"Environ Health"},{"key":"10.1016\/j.blre.2020.100760_bb0510","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.3109\/10428194.2014.894189","article-title":"Acute myeloid leukemia risk by industry and occupation","volume":"55","author":"Tsai","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2020.100760_bb0515","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0165-4608(93)90010-J","article-title":"Myeloid leukemias and myelodysplastic syndromes: chemical exposure, histologic subtype and cytogenetics in a case-control study","volume":"68","author":"Ciccone","year":"1993","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.blre.2020.100760_bb0520","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1289\/ehp.7340","article-title":"Cancer incidence among glyphosate-exposed pesticide applicators in the agricultural health study","volume":"113","author":"De Roos","year":"2005","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.blre.2020.100760_bb0525","first-page":"311","article-title":"Cancer incidence in the agricultural health study after 20 years of follow-up","volume":"30","author":"Lerro","year":"2019","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.blre.2020.100760_bb0530","first-page":"6585","article-title":"Pesticide exposures and other agricultural risk factors for leukemia among men in Iowa and Minnesota","volume":"50","author":"Brown","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2020.100760_bb0535","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1289\/ehp.9301","article-title":"Fonofos exposure and cancer incidence in the agricultural health study","volume":"114","author":"Mahajan","year":"2006","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.blre.2020.100760_bb0540","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/jnci\/djx233","article-title":"Glyphosate use and cancer incidence in the agricultural health study","volume":"110","author":"Andreotti","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.blre.2020.100760_bb0545","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/jnci\/djy005","article-title":"Alachlor use and cancer incidence in the agricultural health study: an updated analysis","volume":"110","author":"Lerro","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.blre.2020.100760_bb0550","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/aje\/kwm182","article-title":"Malathion exposure and the incidence of cancer in the agricultural health study","volume":"166","author":"Bonner","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.blre.2020.100760_bb0555","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.envres.2008.01.010","article-title":"Cancer incidence among pesticide applicators exposed to trifluralin in the agricultural health study","volume":"107","author":"Kang","year":"2008","journal-title":"Environ Res"},{"key":"10.1016\/j.blre.2020.100760_bb0560","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.envres.2009.06.006","article-title":"Cancer incidence among pesticide applicators exposed to butylate in the agricultural health study (AHS)","volume":"109","author":"Lynch","year":"2009","journal-title":"Environ Res"},{"key":"10.1016\/j.blre.2020.100760_bb0565","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1289\/ehp.11318","article-title":"Cancer incidence among pesticide applicators exposed to permethrin in the agricultural health study","volume":"117","author":"Rusiecki","year":"2009","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.blre.2020.100760_bb0570","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1289\/ehp.1103561","article-title":"Atrazine and cancer incidence among pesticide applicators in the agricultural health study (1994-2007)","volume":"119","author":"Freeman","year":"2011","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.blre.2020.100760_bb0575","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/ijc.29416","article-title":"Use of acetochlor and cancer incidence in the agricultural health study","volume":"137","author":"Lerro","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.blre.2020.100760_bb0580","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1002\/ijc.29621","article-title":"Cancer incidence and metolachlor use in the agricultural health study: an update","volume":"137","author":"Silver","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.blre.2020.100760_bb0585","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.envres.2007.09.002","article-title":"Risk of leukaemia among pesticide manufacturing workers: a review and meta-analysis of cohort studies","volume":"106","author":"Van Maele-Fabry","year":"2008","journal-title":"Environ Res"},{"key":"10.1016\/j.blre.2020.100760_bb0590","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.envres.2014.05.028","article-title":"Farm residence and lymphohematopoietic cancers in the Iowa Women's health study","volume":"133","author":"Jones","year":"2014","journal-title":"Environ Res"},{"key":"10.1016\/j.blre.2020.100760_bb0595","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0278-6915(99)00156-8","article-title":"\"IARC group 2A carcinogens\" reported in cigarette mainstream smoke","volume":"38","author":"Smith","year":"2000","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.blre.2020.100760_bb0600","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.yrtph.2004.04.006","article-title":"A review and meta-analysis of formaldehyde exposure and leukemia","volume":"40","author":"Collins","year":"2004","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.blre.2020.100760_bb0605","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/jnci\/djp416","article-title":"Mortality from lymphohematopoietic malignancies and brain cancer among embalmers exposed to formaldehyde","volume":"101","author":"Hauptmann","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.blre.2020.100760_bb0610","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/oem.2003.007476","article-title":"Mortality among a cohort of garment workers exposed to formaldehyde: an update","volume":"61","author":"Pinkerton","year":"2004","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.blre.2020.100760_bb0615","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/jnci\/djg046","article-title":"Extended follow-up of a cohort of british chemical workers exposed to formaldehyde","volume":"95","author":"Coggon","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.blre.2020.100760_bb0620","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/jnci\/djp096","article-title":"Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries: the National Cancer Institute cohort","volume":"101","author":"Beane Freeman","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.blre.2020.100760_bb0625","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/JOM.0000000000000466","article-title":"Formaldehyde exposure and mortality risks from acute myeloid Leukemia and other Lymphohematopoietic malignancies in the US National Cancer Institute cohort study of Workers in Formaldehyde Industries","volume":"57","author":"Checkoway","year":"2015","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.blre.2020.100760_bb0630","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/JOM.0b013e3181ef7e31","article-title":"Formaldehyde and leukemia: an updated meta-analysis and evaluation of bias","volume":"52","author":"Schwilk","year":"2010","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.blre.2020.100760_bb0635","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/jcp.10425","article-title":"Exposure to 900 MHz electromagnetic field induces an unbalance between pro-apoptotic and pro-survival signals in T-lymphoblastoid leukemia CCRF-CEM cells","volume":"198","author":"Marinelli","year":"2004","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.blre.2020.100760_bb0640","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/em.22343","article-title":"Evaluation of the genotoxicity of cell phone radiofrequency radiation in male and female rats and mice following subchronic exposure","volume":"61","author":"Smith-Roe","year":"2020","journal-title":"Environ Mol Mutagen"},{"key":"10.1016\/j.blre.2020.100760_bb0645","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1080\/10428190802441347","article-title":"Case-only study of interactions between DNA repair genes (hMLH1, APEX1, MGMT, XRCC1 and XPD) and low-frequency electromagnetic fields in childhood acute leukemia","volume":"49","author":"Yang","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2020.100760_bb0650","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1080\/10428190802573123","article-title":"DNA repair genes, electromagnetic fields and susceptibility to acute leukemia?","volume":"49","author":"Sharma","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2020.100760_bb0655","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/00039896.1986.9935766","article-title":"Exposure to electromagnetic fields and the risk of leukemia","volume":"41","author":"Sheikh","year":"1986","journal-title":"Arch Environ Health"},{"key":"10.1016\/j.blre.2020.100760_bb0660","first-page":"47","article-title":"Leukemia and occupational exposure to electromagnetic fields: review of epidemiologic surveys","volume":"29","author":"Savitz","year":"1987","journal-title":"J Occup Med"},{"key":"10.1016\/j.blre.2020.100760_bb0665","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00043764-199001000-00017","article-title":"Occupational electromagnetic field exposure, solvent exposure, and leukemia","volume":"32","author":"Gallagher","year":"1990","journal-title":"J Occup Med"},{"key":"10.1016\/j.blre.2020.100760_bb0670","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/oem.60.8.577","article-title":"Occupational exposure to electromagnetic fields and acute leukaemia: analysis of a case-control study","volume":"60","author":"Willett","year":"2003","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.blre.2020.100760_bb0675","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00001648-200003000-00007","article-title":"Radiofrequency exposure and mortality from cancer of the brain and lymphatic\/hematopoietic systems","volume":"11","author":"Morgan","year":"2000","journal-title":"Epidemiology."},{"key":"10.1016\/j.blre.2020.100760_bb0680","first-page":"715","article-title":"Residential and occupational exposure to 50 Hz magnetic fields and hematological cancers in Norway","volume":"14","author":"Tynes","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.blre.2020.100760_bb0685","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/aje\/155.9.810","article-title":"Cancer in Korean war navy technicians: mortality survey after 40 years","volume":"155","author":"Groves","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.blre.2020.100760_bb0690","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1056\/NEJM195507212530302","article-title":"Leukemia in survivors of atomic bombing","volume":"253","author":"Moloney","year":"1955","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2020.100760_bb0695","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2307\/3573095","article-title":"Leukemia in atomic bomb survivors, Hiroshima and Nagasaki, 1 October 1950\u201430 September 1966","volume":"45","author":"Ishimaru","year":"1971","journal-title":"Radiat Res"},{"key":"10.1016\/j.blre.2020.100760_bb0700","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.maturitas.2012.02.009","article-title":"Long-term follow-up of atomic bomb survivors","volume":"72","author":"Sakata","year":"2012","journal-title":"Maturitas."},{"key":"10.1016\/j.blre.2020.100760_bb0705","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s12185-012-1002-4","article-title":"Late effect of atomic bomb radiation on myeloid disorders: leukemia and myelodysplastic syndromes","volume":"95","author":"Tsushima","year":"2012","journal-title":"Int J Hematol"},{"key":"10.1016\/j.blre.2020.100760_bb0710","first-page":"143","article-title":"A case-control analysis of leukemia in accident emergency workers of Chernobyl","volume":"19","author":"Konogorov","year":"2000","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"10.1016\/j.blre.2020.100760_bb0715","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/01.HP.0000281178.75068.e3","article-title":"Leukemia following the Chernobyl accident","volume":"93","author":"Howe","year":"2007","journal-title":"Health Phys"},{"key":"10.1016\/j.blre.2020.100760_bb0720","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2307\/3578592","article-title":"Combined analysis of mortality in three United Kingdom nuclear industry workforces, 1946-1988","volume":"138","author":"Carpenter","year":"1994","journal-title":"Radiat Res"},{"key":"10.1016\/j.blre.2020.100760_bb0725","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.bjc.6690207","article-title":"Cancer mortality and morbidity among plutonium workers at the Sellafield plant of British nuclear fuels","volume":"79","author":"Omar","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.blre.2020.100760_bb0730","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/bmj.38499.599861.E0","article-title":"Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries","volume":"331","author":"Cardis","year":"2005","journal-title":"BMJ."},{"key":"10.1016\/j.blre.2020.100760_bb0735","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/(SICI)1097-0274(199901)35:1<21::AID-AJIM4>3.0.CO;2-X","article-title":"Effects of exposure to external ionizing radiation on cancer mortality in nuclear workers monitored for radiation at Rocketdyne\/atomics international","volume":"35","author":"Ritz","year":"1999","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.blre.2020.100760_bb0740","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1667\/RR0724.1","article-title":"Risk of chronic myeloid and acute leukemia mortality after exposure to ionizing radiation among workers at four U.S. nuclear weapons facilities and a nuclear naval shipyard","volume":"167","author":"Schubauer-Berigan","year":"2007","journal-title":"Radiat Res"},{"key":"10.1016\/j.blre.2020.100760_bb0745","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1667\/0033-7587(2003)159[0228:SAOMON]2.0.CO;2","article-title":"Second analysis of mortality of nuclear industry workers in Japan, 1986-1997","volume":"159","author":"Iwasaki","year":"2003","journal-title":"Radiat Res"},{"key":"10.1016\/j.blre.2020.100760_bb0750","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1667\/RR3170","article-title":"Analysis of mortality among Canadian nuclear power industry workers after chronic low-dose exposure to ionizing radiation","volume":"161","author":"Zablotska","year":"2004","journal-title":"Radiat Res"},{"key":"10.1016\/j.blre.2020.100760_bb0755","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1539\/joh.48.358","article-title":"Cancer incidence among Australian nuclear industry workers","volume":"48","author":"Habib","year":"2006","journal-title":"J Occup Health"},{"key":"10.1016\/j.blre.2020.100760_bb0760","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/ijc.30544","article-title":"Examining temporal effects on cancer risk in the international nuclear workers' study","volume":"140","author":"Daniels","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.blre.2020.100760_bb0765","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1016\/S2352-3026(15)00094-0","article-title":"Ionising radiation and risk of death from leukaemia and lymphoma in radiation-monitored workers (INWORKS): an international cohort study","volume":"2","author":"Leuraud","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.blre.2020.100760_bb0770","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ijc.10811","article-title":"Cancer and other causes of mortality among radiologic technologists in the United States","volume":"103","author":"Mohan","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.blre.2020.100760_bb0775","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1667\/RR13542.1","article-title":"Radiation organ doses received in a nationwide cohort of U.S. radiologic technologists: methods and findings","volume":"182","author":"Simon","year":"2014","journal-title":"Radiat Res"},{"key":"10.1016\/j.blre.2020.100760_bb0780","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1148\/radiol.2332031119","article-title":"Cancer risks among radiologists and radiologic technologists: review of epidemiologic studies","volume":"233","author":"Yoshinaga","year":"2004","journal-title":"Radiology."},{"key":"10.1016\/j.blre.2020.100760_bb0785","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/oxfordjournals.aje.a008722","article-title":"Cohort study of air Canada pilots: mortality, cancer incidence, and leukemia risk","volume":"143","author":"Band","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.blre.2020.100760_bb0790","first-page":"699","article-title":"Cancer incidence among 10,211 airline pilots: a Nordic study","volume":"74","author":"Pukkala","year":"2003","journal-title":"Aviat Space Environ Med"},{"key":"10.1016\/j.blre.2020.100760_bb0795","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/00039890409605165","article-title":"Risk of cancer as a result of community exposure to gasoline vapors","volume":"59","author":"Patel","year":"2004","journal-title":"Arch Environ Health"},{"key":"10.1016\/j.blre.2020.100760_bb0800","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.envres.2011.03.009","article-title":"Risk of leukemia as a result of community exposure to gasoline vapors: a follow-up study","volume":"111","author":"Talbott","year":"2011","journal-title":"Environ Res"},{"key":"10.1016\/j.blre.2020.100760_bb0805","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.scitotenv.2013.12.034","article-title":"Personal exposure of primary school children to BTEX, NO(2) and ozone in Eskisehir, Turkey: relationship with indoor\/outdoor concentrations and risk assessment","volume":"473-474","author":"Demirel","year":"2014","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.blre.2020.100760_bb0810","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/aje\/kww130","article-title":"Residential proximity to gasoline stations and risk of childhood Leukemia","volume":"185","author":"Infante","year":"2017","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.blre.2020.100760_bb0815","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-8166-7-15","article-title":"Monitoring of gas station attendants exposure to benzene, toluene, xylene (BTX) using three-color chromosome painting","volume":"7","author":"Santiago","year":"2014","journal-title":"Mol Cytogenet"},{"key":"10.1016\/j.blre.2020.100760_bb0820","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2486\/indhealth.2017-0126","article-title":"Genotoxic effects of occupational exposure to benzene in gasoline station workers","volume":"56","author":"Salem","year":"2018","journal-title":"Ind Health"},{"key":"10.1016\/j.blre.2020.100760_bb0825","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15040735","article-title":"Epigenetic and transcriptional modifications in repetitive elements in Petrol Station workers exposed to benzene and MTBE","volume":"15","author":"Rota","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.blre.2020.100760_bb0830","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16152627","article-title":"Spatial analysis of industrial benzene emissions and cancer incidence rates in Texas","volume":"16","author":"Mungi","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.blre.2020.100760_bb0835","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/10962247.2015.1081652","article-title":"Source attribution and quantification of benzene event emissions in a Houston ship channel community based on real-time mobile monitoring of ambient air","volume":"66","author":"Olaguer","year":"2016","journal-title":"J Air Waste Manag Assoc"},{"key":"10.1016\/j.blre.2020.100760_bb0840","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1021\/es049316n","article-title":"Temporal changes in U.S. benzene emissions inferred from atmospheric measurements","volume":"39","author":"Fortin","year":"2005","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.blre.2020.100760_bb0845","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.32202","article-title":"Residential ambient benzene exposure in the United States and subsequent risk of hematologic malignancies","author":"Teras","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.blre.2020.100760_bb0850","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(12)60815-0","article-title":"Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study","volume":"380","author":"Pearce","year":"2012","journal-title":"Lancet."},{"key":"10.1016\/j.blre.2020.100760_bb0855","doi-asserted-by":"crossref","first-page":"f2360","DOI":"10.1136\/bmj.f2360","article-title":"Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians","volume":"346","author":"Mathews","year":"2013","journal-title":"BMJ."},{"key":"10.1016\/j.blre.2020.100760_bb0860","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/bjc.2015.415","article-title":"Relationship between paediatric CT scans and subsequent risk of leukaemia and brain tumours: assessment of the impact of underlying conditions","volume":"114","author":"Berrington de Gonzalez","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.blre.2020.100760_bb0865","article-title":"Exposure to tomographic scans and cancer risks","volume":"4","author":"Shao","year":"2019","journal-title":"JNCI Cancer Spectrum"},{"key":"10.1016\/j.blre.2020.100760_bb0870","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.HP.0000356672.44380.b7","article-title":"NCRP report no. 160, ionizing radiation exposure of the population of the United States, medical exposure--are we doing less with more, and is there a role for health physicists?","volume":"97","author":"Schauer","year":"2009","journal-title":"Health Phys"},{"key":"10.1016\/j.blre.2020.100760_bb0875","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00004032-200407000-00008","article-title":"The U.S. Environmental Protection Agency's assessment of risks from indoor radon","volume":"87","author":"Pawel","year":"2004","journal-title":"Health Phys"},{"key":"10.1016\/j.blre.2020.100760_bb0880","doi-asserted-by":"crossref","first-page":"A29","DOI":"10.1088\/0952-4746\/29\/2A\/S03","article-title":"Human exposure to high natural background radiation: what can it teach us about radiation risks?","volume":"29","author":"Hendry","year":"2009","journal-title":"J Radiol Prot"},{"key":"10.1016\/j.blre.2020.100760_bb0885","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2105\/AJPH.2012.300926","article-title":"Radon, smoking, and lung cancer: the need to refocus radon control policy","volume":"103","author":"Lantz","year":"2013","journal-title":"Am J Public Health"},{"key":"10.1016\/j.blre.2020.100760_bb0890","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1088\/0952-4746\/29\/2\/001","article-title":"Dose to red bone marrow of infants, children and adults from radiation of natural origin","volume":"29","author":"Kendall","year":"2009","journal-title":"J Radiol Prot"},{"key":"10.1016\/j.blre.2020.100760_bb0895","doi-asserted-by":"crossref","DOI":"10.1177\/1559325815592391","article-title":"Cancer mortality among people living in areas with various levels of natural background radiation","volume":"13","author":"Dobrzynski","year":"2015","journal-title":"Dose Response"},{"key":"10.1016\/j.blre.2020.100760_bb0900","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/S0140-6736(00)02300-X","article-title":"Residential radon exposure and adult acute leukaemia","volume":"355","author":"Law","year":"2000","journal-title":"Lancet."},{"key":"10.1016\/j.blre.2020.100760_bb0905","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.HP.0000198787.93305.35","article-title":"Childhood leukemia incidence and exposure to indoor radon, terrestrial and cosmic gamma radiation","volume":"90","author":"Evrard","year":"2006","journal-title":"Health Phys"},{"key":"10.1016\/j.blre.2020.100760_bb0910","first-page":"536","article-title":"Domestic radon and childhood cancer in Denmark","volume":"19","author":"Raaschou-Nielsen","year":"2008","journal-title":"Epidemiology."},{"key":"10.1016\/j.blre.2020.100760_bb0915","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/HP.0b013e3181ad8018","article-title":"Radon and leukemia in the Danish study: another source of dose","volume":"97","author":"Harley","year":"2009","journal-title":"Health Phys"},{"key":"10.1016\/j.blre.2020.100760_bb0920","first-page":"227","article-title":"Low-dose cancer risk modeling must recognize up-regulation of protection","volume":"8","author":"Feinendegen","year":"2009","journal-title":"Dose Response"},{"key":"10.1016\/j.blre.2020.100760_bb0925","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/genetics\/148.4.1667","article-title":"Rates of spontaneous mutation","volume":"148","author":"Drake","year":"1998","journal-title":"Genetics."},{"key":"10.1016\/j.blre.2020.100760_bb0930","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/cr.2008.4","article-title":"The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases","volume":"18","author":"McCulloch","year":"2008","journal-title":"Cell Res"},{"key":"10.1016\/j.blre.2020.100760_bb0935","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1101\/sqb.2009.74.027","article-title":"Evolving views of DNA replication (in)fidelity","volume":"74","author":"Kunkel","year":"2009","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1016\/j.blre.2020.100760_bb0940","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1749-6632.1992.tb38652.x","article-title":"Oxidants are a major contributor to aging","volume":"663","author":"Ames","year":"1992","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.blre.2020.100760_bb0945","doi-asserted-by":"crossref","first-page":"7915","DOI":"10.1073\/pnas.90.17.7915","article-title":"Oxidants, antioxidants, and the degenerative diseases of aging","volume":"90","author":"Ames","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2020.100760_bb0950","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.1260825","article-title":"Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions","volume":"347","author":"Tomasetti","year":"2015","journal-title":"Science."},{"key":"10.1016\/j.blre.2020.100760_bb0955","doi-asserted-by":"crossref","first-page":"17998","DOI":"10.1038\/s41598-017-18278-x","article-title":"Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: a meta-analysis","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.blre.2020.100760_bb0960","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.canep.2015.12.005","article-title":"Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes","volume":"40","author":"Poynter","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.blre.2020.100760_bb0965","first-page":"427","article-title":"Anthropometric characteristics and risk of lymphoid and myeloid leukemia in the European prospective investigation into cancer and nutrition (EPIC)","volume":"24","author":"Saberi Hosnijeh","year":"2013","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.blre.2020.100760_bb0970","first-page":"489","article-title":"Lifestyle factors and the risk of adult leukemia in Canada","volume":"16","author":"Kasim","year":"2005","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.blre.2020.100760_bb0975","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.canep.2015.09.003","article-title":"Epidemiology of adult acute myeloid leukemia: impact of exposures on clinical phenotypes and outcomes after therapy","volume":"39","author":"Finn","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.blre.2020.100760_bb0980","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrendo.2017.90","article-title":"Adapting to obesity with adipose tissue inflammation","volume":"13","author":"Reilly","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.blre.2020.100760_bb0985","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.bjc.6604935","article-title":"Risks of myeloid malignancies in patients with autoimmune conditions","volume":"100","author":"Anderson","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.blre.2020.100760_bb0990","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jamaoncol.2016.6435","article-title":"Association of Therapy for autoimmune disease with Myelodysplastic syndromes and acute myeloid Leukemia","volume":"3","author":"Ertz-Archambault","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.blre.2020.100760_bb0995","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/leu.2011.251","article-title":"IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromes","volume":"26","author":"Pardanani","year":"2012","journal-title":"Leukemia."},{"key":"10.1016\/j.blre.2020.100760_bb1000","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0145-2126(01)00193-X","article-title":"In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome","volume":"26","author":"Flores-Figueroa","year":"2002","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2020.100760_bb1005","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/cncr.21234","article-title":"Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome","volume":"104","author":"Meyers","year":"2005","journal-title":"Cancer."},{"key":"10.1016\/j.blre.2020.100760_bb1010","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1182\/blood-2010-01-262071","article-title":"Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia","volume":"116","author":"Kornblau","year":"2010","journal-title":"Blood."},{"key":"10.1016\/j.blre.2020.100760_bb1015","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3324\/haematol.2010.030536","article-title":"Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes","volume":"96","author":"Feng","year":"2011","journal-title":"Haematologica."},{"key":"10.1016\/j.blre.2020.100760_bb1020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000065722","article-title":"Circulating levels of thrombopoietic and inflammatory cytokines in patients with acute myeloblastic leukemia and myelodysplastic syndrome","volume":"63","author":"Hsu","year":"2002","journal-title":"Oncology."},{"key":"10.1016\/j.blre.2020.100760_bb1025","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1200\/JCO.2012.45.5626","article-title":"Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes","volume":"31","author":"Pellagatti","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2020.100760_bb1030","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/leu.2010.31","article-title":"Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells","volume":"24","author":"Pellagatti","year":"2010","journal-title":"Leukemia."},{"key":"10.1016\/j.blre.2020.100760_bb1035","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","article-title":"Epidemiology of acute myeloid leukemia: recent progress and enduring challenges","volume":"36","author":"Shallis","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2020.100760_bb1040","first-page":"658","article-title":"Cancer in Alaskan Indians, Eskimos, and Aleuts, 1969-83: implications for etiology and control","volume":"104","author":"Lanier","year":"1989","journal-title":"Public Health Rep"},{"key":"10.1016\/j.blre.2020.100760_bb1045","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.phr.2004.05.009","article-title":"Patterns in cancer incidence among American Indians\/Alaska natives, United States, 1992-1999","volume":"119","author":"Paltoo","year":"2004","journal-title":"Public Health Rep"},{"key":"10.1016\/j.blre.2020.100760_bb1050","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/cncr.23044","article-title":"Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska natives","volume":"110","author":"Espey","year":"2007","journal-title":"Cancer."},{"key":"10.1016\/j.blre.2020.100760_bb1055","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/cncr.23734","article-title":"Cancer among American Indians and Alaska natives in the United States, 1999-2004","volume":"113","author":"Wiggins","year":"2008","journal-title":"Cancer."},{"issue":"Suppl. 3","key":"10.1016\/j.blre.2020.100760_bb1060","doi-asserted-by":"crossref","first-page":"S377","DOI":"10.2105\/AJPH.2013.301673","article-title":"Disparities in cancer mortality and incidence among American Indians and Alaska natives in the United States","volume":"104","author":"White","year":"2014","journal-title":"Am J Public Health"},{"key":"10.1016\/j.blre.2020.100760_bb1065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3109\/02841869609096993","article-title":"Malignant neoplasms of the lymphatic and haematopoietic system in circumpolar Inuit","volume":"35","author":"Lanier","year":"1996","journal-title":"Acta Oncol"},{"key":"10.1016\/j.blre.2020.100760_bb1070","series-title":"National Cancer Institute Surveillance, Epidemiology, and End Results Program: National Cancer Institute. Bethesda, MD","article-title":"About the SEER registries","year":"2018"},{"key":"10.1016\/j.blre.2020.100760_bb1075","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3109\/1354750X.2012.700950","article-title":"The combined effect of persistent organic pollutants in the serum POP mixture in Greenlandic Inuit: xenoestrogenic, xenoandrogenic and dioxin-like transactivities","volume":"17","author":"Kruger","year":"2012","journal-title":"Biomarkers."},{"key":"10.1016\/j.blre.2020.100760_bb1080","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0045-6535(97)00442-6","article-title":"PCBs and dioxin-like compounds in plasma of adult Inuit living in Nunavik (Arctic Quebec)","volume":"34","author":"Ayotte","year":"1997","journal-title":"Chemosphere."},{"key":"10.1016\/j.blre.2020.100760_bb1085","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.blre.2020.100760_bb1090","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1186\/s12885-016-2710-6","article-title":"Connect MDS\/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study","volume":"16","author":"Steensma","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.blre.2020.100760_bb1095","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1182\/blood.V128.22.3548.3548","article-title":"Current diagnosis patterns for acute myeloid Leukemia (AML) in clinical practice compared with World Health Organization (WHO) 2008 recommendations: outcomes from the CONNECT\u00ae Myelodysplastic syndromes (MDS) and AML disease registry","volume":"128","author":"George","year":"2016","journal-title":"Blood."},{"key":"10.1016\/j.blre.2020.100760_bb1100","author":"National Heart, Lung, and Blood Institute (NHLBI)"},{"key":"10.1016\/j.blre.2020.100760_bb1105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cbi.2011.02.010","article-title":"Benzene, the exposome and future investigations of leukemia etiology","volume":"192","author":"Smith","year":"2011","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.blre.2020.100760_bb1110","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1158\/1055-9965.EPI-05-0456","article-title":"Complementing the genome with an \"exposome\": the outstanding challenge of environmental exposure measurement in molecular epidemiology","volume":"14","author":"Wild","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.blre.2020.100760_bb1115","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1126\/science.aay3164","article-title":"The exposome and health: where chemistry meets biology","volume":"367","author":"Vermeulen","year":"2020","journal-title":"Science."},{"key":"10.1016\/j.blre.2020.100760_bb1120","doi-asserted-by":"crossref","first-page":"38012","DOI":"10.1038\/srep38012","article-title":"Association between dioxin and cancer incidence and mortality: a meta-analysis","volume":"6","author":"Xu","year":"2016","journal-title":"Sci Rep"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X20301107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X20301107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T20:27:55Z","timestamp":1759436875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X20301107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":223,"alternative-id":["S0268960X20301107"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2020.100760","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenging the concept of de novo acute myeloid leukemia: Environmental and occupational leukemogens hiding in our midst","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2020.100760","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100760"}}